Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

5,027 public trials 1,169 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Recruiting

A Study of MGC028 in Participants With Advanced Solid Tumors

NCT06723236

Conditions
Adenocarcinoma, Advanced Solid Tumors, Carcinoma, +21 more
Locations
  • UCSF - Helen Diller Family Cancer Center San Francisco, California, United States
  • Mass General Brigham Boston, Massachusetts, United States
  • Dana Farber/Harvard Cancer Center Boston, Massachusetts, United States
  • South Texas Accelerated Research Therapeutics (START) Midwest Grand Rapids, Michigan, United States
View Trial Details
Recruiting

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

NCT06128551

Conditions
Adenocarcinoma, Adnexal Diseases, Appendiceal Neoplasms, +59 more
Locations
  • City of Hope Duarte, California, United States
  • UC IRVINE Health Orange, California, United States
  • UC Davis Comprehensive Cancer Center Sacramento, California, United States
  • Stanford Cancer Institute Stanford, California, United States
View all 53 locations
View Trial Details
Recruiting

Gemcitabine and Oxaliplatin Chemotherapy With or Without a Floxuridine and Dexamethasone Pump in People With Cholangiocarcinoma That Cannot Be Removed With Surgery

NCT04891289

Conditions
Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations
  • National Heart, Lung, and Blood Institute (NIH) (Data Collection Only) Bethesda, Maryland, United States
  • Washington University (Data Collection Only) St Louis, Missouri, United States
  • Memorial Sloan Kettering Basking Ridge - Limited Protocol Activities Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth - Limited Protocol Activities Middletown, New Jersey, United States
View Trial Details
Recruiting

Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors

NCT05732831

Conditions
Adenocarcinoma, Adenoma, Carcinoma, +21 more
Locations
  • Stanford University Palo Alto, California, United States
  • Grand Valley Oncology Grand Junction, Colorado, United States
  • Florida Cancer Specialists & Research Institute Lake Mary, Florida, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 26 locations
View Trial Details

Related conditions